A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)

NCT01533428 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathy
Pain

Interventions

DRUG: Capsaicin 8%
DRUG: Placebo

Sponsor

Astellas Pharma Inc